Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Pediatr Allergy Immunol. 2021 Mar 20;32(5):971–979. doi: 10.1111/pai.13480

Table 2.

Adverse Events

Adult Pediatric
N=10 N=25
Number of Participants with at Least One Event 4 (40%) 8 (32%)
 Most Frequent Adverse Event- Headache 2 (20%) 2 (8%)
Number of Adverse Events 9 12
 Adverse Events Related to the Nasal Allergen Challenge 6 (67%) 6 (50%)
 Serious Adverse Events Related to the Nasal Allergen Challenge 1 0